Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
treatment source : Spacfeed.com save search
FDA approves Ligand's molluscum contagiosum treatment – Pharmaceutical Technology
Published: 2024-01-08 (Crawled : 10:00) - spacfeed.com
CPT 4 | $95.29 -0.03% -0.3% 450K
|
Finance
|
| O: -0.46%
H: 1.63%
C: 1.54%
molluscum fda treatment technology
EY Abogados advises on the acquisition of 5 waste treatment plants … – Iberian Lawyer
Published: 2023-11-21 (Crawled : 15:30) - spacfeed.com
ARVL | News | $0.49 0.37% 2.5M
|
Manufacturing
|
| O: 3.7%
H: 0.0%
C: 0.0%
plants treatment acquisition
Analyst Bullish On Calidi Biotherapeutics, Newly Listed Cancer Treatment Player – Calidi Biotherapeutics – Benzinga
Published: 2023-10-09 (Crawled : 19:00) - spacfeed.com
TAC | News | $6.43 3.38% 0.93% 980K
|
Utilities
|
| O: 0.23%
H: 0.64%
C: 0.23%
cancer treatment
Study supports stroke treatment from Imperative Care – Mass Device
Published: 2023-06-08 (Crawled : 16:00) - spacfeed.com
CFFS | $10.84 -0.27% 200
|
n/a
|
| O: 0.0%
H: 2.11%
C: 0.19%
device stroke treatment care study
HDL Therapeutics Inc Plans to Become Publicly Traded via a Business Combination With $225 Million Swiftmerge (NASDAQ : IVCP) With Goal to Transform Cardiovascular Disease Treatment – Marketscreener.com
Published: 2023-04-24 (Crawled : 18:00) - spacfeed.com
MODD 4 | $1.7 0.58% 39K
|
|
| O: -1.05%
H: 1.86%
C: 1.86%
disease business treatment therapeutics cardiovascular
Global Liver Fibrosis Treatment Market is Estimated to be valued at … – Digital Journal
Published: 2023-04-24 (Crawled : 12:00) - spacfeed.com
BRLI | $4.7 31.92% 370K
|
Finance
| Email alert
Add to watchlist
liver treatment fibrosis global market
Recent Decisions Further Define Treatment of SPACs in Delaware … – Law.com
Published: 2023-03-22 (Crawled : 13:20) - spacfeed.com
DWAC | $49.95 7.47% 22M
|
|
| O: -0.88%
H: 0.89%
C: -1.55%
treatment
Press Release : Sanofi to acquire Provention Bio, adding to portfolio TZIELD, the first disease-modifying treatment for the delay of Stage 3 type 1 diabetes (T1D) – Marketscreener.com
Published: 2023-03-13 (Crawled : 07:00) - spacfeed.com
ARKO A | $4.49 0.22% 0.44% 550K
|
|
| O: -1.39%
H: 2.47%
C: -0.47%
SNY | News | $45.39 -1.56% -1.58% 4.3M
|
Health Technology
|
| O: -0.81%
H: 0.0%
C: 0.0%
treatment acquire diabetes sanofi
AUM Biosciences Receives U.S. FDA Rare Pediatric Disease Designation for AUM302 for Treatment of Neuroblastoma – Yahoo Finance
Published: 2023-01-05 (Crawled : 13:20) - spacfeed.com
LTUM | $0.0364 -3.96% 33.16% 230K
|
Mining, Quarrying, and Oil and ...
|
| O: 0.0%
H: 0.21%
C: -4.76%
aum302 treatment fda rare designation disease
Gainers vs Losers
| 59% | 41% |
Top 10 Gainers
AGBA | News | $1.03 157.5% 57.94% 120M
|
Finance
ZCMD | $1.45 5.84% 52.1% 2.3M
|
Commercial Services
INVO | $1.52 100.0% 51.13% 5M
|
Health Technology
ISPC | $0.421 97.65% 49.53% 37M
|
Professional, Scientific, and T...
WLGS | News | $0.5 45.65% 470K
|
OST | $0.509 23.81% 45.26% 90K
|
GDHG | $0.263 21.76% 40.66% 3.1M
|
XPON | News | $3.15 63.21% 37.74% 16M
|
TIRX | $0.8 65.02% 30.74% 58M
|
BNTC | News | $6.82 42.08% 30.64% 3.5M
|
Health Technology
Your saved searches
Save your searches and get alerts when important news are released.